BeOne Medicines (ONC) Assets Average (2016 - 2026)

BeOne Medicines (ONC) has 11 years of Assets Average data on file, last reported at $8.4 billion in Q1 2026.

• On a quarterly basis, Assets Average rose 42.34% year-over-year to $8.4 billion in Q1 2026; TTM through Mar 2026 was $8.4 billion, a 42.34% increase from a year earlier, with the FY2025 full-year figure at $7.1 billion, up 20.32% from the prior year.
• Assets Average for Q1 2026 stood at $8.4 billion, up from $7.9 billion in the prior quarter.
• Over the last five years, Assets Average for ONC reached as high as $8.4 billion in Q1 2026 and fell as low as $5.6 billion in Q3 2023.
• Historically, Assets Average has averaged $6.5 billion across 5 years, with a median of $5.9 billion in 2025.
• Across the five-year window, Assets Average jumped 44.96% in 2022 and plunged 30.92% in 2023, its largest moves.
• Year by year, Assets Average stood at $6.1 billion in 2022, then decreased by 7.18% to $5.7 billion in 2023, then climbed by 3.72% to $5.9 billion in 2024, then soared by 34.63% to $7.9 billion in 2025, then climbed by 5.82% to $8.4 billion in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $8.4 billion in Q1 2026, $7.9 billion in Q4 2025, and $7.0 billion in Q3 2025.